logo
Select company
Select metric
$ 9.74MNet Cash Flow - Financing
VS
Market
34
Sector
44
Industry
53
History
36
$ 0.18Close
$ 0.16 - $ 11.69 52-Week Range
Ticker Information

Ticker

ABP

Company Name

ABPRO HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ABPRO HOLDINGS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ABP - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 9.74M
3/31/2025$ 40.97M
12/31/2024$ 11.16M
9/30/2024$ 281.89M
6/30/2024$ -27.34M
3/31/2024$ -304.41M
12/31/2023$ -274.73M
9/30/2023$ -276.54M
6/30/2023$ -276.55M
3/31/2023$ -12K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ABPRO HOLDINGS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 0.
  • Over the past 5 years, ABPRO HOLDINGS INC's average CF - Financing has been $ -42.38M.
  • The median CF - Financing for ABPRO HOLDINGS INC during this period was $ -6K
  • ABPRO HOLDINGS INC reached its highest CF - Financing over the past 5 years at $ 307.25M.
  • The lowest CF - Financing recorded by ABPRO HOLDINGS INC in the same timeframe $ -304.41M

ABPRO HOLDINGS INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
SABS : SAB BIOTHERAPEUTICS INC $ -805KHCWB : HCW BIOLOGICS INC $ 13.99MNXL : NEXALIN TECHNOLOGY INC $ 4.52MCTXR : CITIUS PHARMACEUTICALS INC $ 13.76MLIXT : LIXTE BIOTECHNOLOGY HOLDINGS INC $ 904.23KCVKD : CADRENAL THERAPEUTICS INC $ 12.21MVIVS : VIVOSIM LABS INC $ 4.28MAIM : AIM IMMUNOTECH INC $ 2.19MBCTX : BRIACELL THERAPEUTICS CORP $ 36.31MBGMS : BIO GREEN MED SOLUTION INC $ 7.14M

Similar metrics to CF - Financing:

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

ABP - Net Cash Flow - Financing, Last 5 years

$ -304.41M

Minimum

Mar 31, 2024

$ 307.25M

Maximum

Dec 31, 2022

$ -42.38M

Average

$ -6K

Median

CF - Financing Benchmark Analysis

 The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.27M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.27M